Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT

Bone Marrow Transplantation

Volumn 43, Issue 4, 2009, Pages 293-300

  Markiewicz, M ^a   Siekiera, U ^b   Karolczyk, A ^a   Szymszal, J ^c   Helbig, G ^a   Wojnar, J ^a   Dzierzak Mietla, M ^a   Kyrcz Krzemien, S ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Regional Blood Center   (Poland)

^c SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HISTOCOMPATIBILITY ANTIGEN; HISTOCOMPATIBILITY ANTIGEN ACC 1; HISTOCOMPATIBILITY ANTIGEN ACC 2; HISTOCOMPATIBILITY ANTIGEN HA 1; HISTOCOMPATIBILITY ANTIGEN HA 2; HISTOCOMPATIBILITY ANTIGEN HA 3; HISTOCOMPATIBILITY ANTIGEN HA 8; HISTOCOMPATIBILITY ANTIGEN HB 1; HISTOCOMPATIBILITY ANTIGEN HWA 10; HISTOCOMPATIBILITY ANTIGEN HWA 9; HISTOCOMPATIBILITY ANTIGEN HY; HISTOCOMPATIBILITY ANTIGEN UGT2B17; METHOTREXATE; MINOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RELAPSE; DONOR; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; ALLELES; DISEASE-FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; MULTIVARIATE ANALYSIS; PHENOTYPE; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 61449136809     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.326     Document Type: Article

References (47)

1. Mullighan CG, Bardy PG. New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 127-144.
2. Kikuchi T, Naruse TK, Onizuka M, Li S, Kimura T, Oka A et al. Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22. Immunogenetics 2007; 59: 99-108.
3. Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol 2004; 127: 479-490.
4. Bertinetto FE, Dall'Omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L et al. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int J Immunogenetics 2006; 33: 375-384.
5. Mullally A, Ritz J. Beyond HLA: The significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 1355-1362.
6. Spierings E, Drabbels J, Hendriks M, Pool J, Spruyt-Gerritse M, Claas F et al. A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PlosOne 2006; 1: 1-10.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Stat Assoc 1958; 53: 457-481.
8. Klein JP, Rizzo JD, Zhang MJ, Kleiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 1: Unadjusted analysis. Bone Marrow Transplant 2001; 28 909-915.
9. Szydlo RM. Statistical evaluation of HSCT data. In: Red J Apperley, Carreras E, Gluckman E, Gratwohl A, Masszi T (eds). W: The EBMT Handbook. Haematopoietic stem cell transplantation. European School of Haematology: Paris, 2004, pp 342-350.
10. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risk: New representations of old estimators. Stat Med 1999; 18: 695-706.
11. Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J et al Phenotype frequencies of autosomal minor Histocompatibility antigens display signi.cant differences among ethnic populations. Plos Genetics 2007; 3: 1108-1119.
12. Goulmy E. Minor histocompatibility antigens: From transplantation problems to therapy of cancer. Hum Immunol 2006; 67: 433-438.
13. Rice J, Dunn S, Piper K, Buchan SL, Moss PA, Stevenson FK. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens. Cancer Res 2006; 66: 5436-5442.
14. Hambach L, Goulmy E. Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Immunol 2005; 17: 202-210.
15. Pietz BC, Warden MB, Duchateau BK, Ellis TM. Multiplex genotyping of human minor histocompatibility antigens. Hum Immunol 2005; 66 1174-1182.
16. The International HapMap Consortium. The international HapMap project. Nature 2003; 426: 789-796.
17. Siekiera U, Janusz J. Human minor histocompatibility antigens (mHAg) in HLA-ABC, DR, DQ matched sib-pairs. Transf Clin Biol 2001; 8 (suppl.1): 163s-164s (abstract).
18. Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004; 103: 347-352.
19. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999; 5: 839-842.
20. Markiewicz M, Siekiera U, Wojnar J, Wylezoł I, Karolczyk A, Giebel S et al. In.uence of immunoreactive minor histocompatibility antigens mismatches on probability of graft-versus-host disease and relapse after hematopoietic stem cell transplantation from HLA-matched unrelated donors. Bone Marrow Transplant 2007; 39 (suppl.1): S310 (abstract).
21. Gahrton G. Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation. Best Pract Res Clin Haematol 2007; 20: 219-229.
22. Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM et al. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 758-769.
23. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281-285.
24. Tseng LH, Lin MT, Hansen JA, Gooley T, Pei J, Smith AG et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 1999; 94: 2911-2914.
25. Gallardo D, Arostegui JI, Balas A, Torres A, Caballero D, Carreras E et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114: 931-936.
26. Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E et al Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72: 699-706.
27. Perez-Garcia A, De la Camara R, Torres A, Gonzalez M, Jimenez A, Gallardo D. Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation. Haematologica 2005; 90: 1723-1724.
28. Lin MT, Gooley T, Hansen JA, Tseng LH, Martin EG, Singleton K et al Absence of statistically significant correlation between disparity for the minor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood 2001; 98 3172-3173.
29. Murata M, Emi N, Hirabayashi N, Hamaguchi M, Goto S, Wakita A et al No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients. Int J Hematol 2000; 72: 371-375.
30. Tait BD, Maddison R, McCluskey J, Deayton S, Heatley S, Lester S et al. Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA-identical siblings. Transplant Proc 2001; 33: 1760-1761.
31. Park MJ, Choi HB, Jang JP, Kim HJ, Kim YJ, Eom KS et al. Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT. Bone Marrow Transplant 2007; 40: 723-728.
32. Teshima T, Ordemann R, Reddy P, Teshima T, Ordemann R, Reddy P et al Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002; 8: 575-581.
33. Teshima T, Ferrara JL. Understanding the alloresponse: New approaches to graft-versus-host disease prevention. Semin Hematol 2002; 39 15-22.
34. Antin JH. Approaches to graft-vs-host disease. Pediatr Transplant 2005; 9 (Suppl.7): 71-75.
35. Laylor R, Cannella L, Simpson E, Dazzi F. Minor histocompatibility antigens and stem cell transplantation. Vox Sanguinis 2004; 87 (suppl.2): S11-S14.
36. Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft versus host disease and disease remission. Blood 2005; 105: 2973-2978.
37. Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC et al. Bone marrow transplantation from related donors other than HLA-identical siblings: Effect of T-cell depletion. Bone Marrow Transplant 1991; 7: 443-452.
38. Voogt PJ, Fibbe WE, Marijt WA, Goulmy E, Veenhof WF, Hamilton M et al Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 1990; 335: 131-134.
39. Marijt WA, Kernan NA, Diaz-Barrientos T, Veenhof WF, O'Reilly RJ, Willemze R et al. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Bone Marrow Transplant 1995; 16: 125-132.
40. Rotzschke O, Falk K, Wallny HJ, Faath S, Rammensee HG. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 1989; 249: 283-287.
41. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Alloimmunity to human H-Y. Lancet 1976; 2: 1206.
42. Stern M, Passweg JR, Locasciulli A, Socie G, Schrezenmeier H, Bekassy AN et al. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation 2006; 82: 218-226.
43. Pierce RA, Field ED, Mutis T, Golovina TN, Von Kap-Herr C, Wilke M et al. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 2001; 167: 3223-3230.
44. Dolstra H, Fredrix H, Preijers F, Goulmy E, Figdor CG, de Witte TM et al. Recognition of B cell leukemia-associated minor histocompatibility antigen by CTL. J Immunol 1997; 158: 560-565.
45. Falkenburg JHF, Goselink HM, van der Harst D, Falkenburg JH, Goselink HM, van der Harst D et al. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T-lymphocytes. J Exp Med 1991; 174: 27-33.
46. Gratwohl A, Stern M, Brand R, de Witte T, Sureda A, Rocha V et al. Impact of the donor recipient sex combination in hematopoietic stem cell transplantation: H-Y as a model for the interaction between major and minor histocompatibility antigens. Blood 2007; 110 (Part 1): 481 (abstract).
47. Katagiri T, Shiobara S, Nakao S, Wakano M, Muranaka E, Kuba N et al Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLAidentical stem cell transplantation in Japan. Bone Marrow Transplant 2006; 38: 681-686.